Bactrim Dosing for Skin Cellulitis
For uncomplicated skin cellulitis in a patient with normal renal function (normal BUN, creatinine, and GFR), the standard dose is Bactrim DS (double strength: 800mg sulfamethoxazole/160mg trimethoprim) twice daily for 5 days, with treatment extended only if the infection has not improved by day 5 1, 2.
Dosing Algorithm
Standard Dosing (Normal Renal Function)
- Dose: 1 Bactrim DS tablet (or 2 regular strength tablets) every 12 hours
- Duration: 5 days initially 1, 3
- Extension criteria: Continue beyond 5 days only if clinical improvement has not occurred 1
When to Use Bactrim for Cellulitis
The IDSA guidelines specify that Bactrim should be reserved for cellulitis cases with specific MRSA risk factors 1, 3:
- Penetrating trauma or injection drug use
- Purulent drainage present
- Evidence of MRSA infection elsewhere
- Known MRSA nasal colonization
- Systemic inflammatory response syndrome (SIRS)
Important caveat: For typical non-purulent cellulitis without these risk factors, beta-lactam antibiotics (like cephalexin) targeting streptococci are preferred first-line agents 1, 3. A recent double-blind study demonstrated that Bactrim plus cephalexin was no more effective than cephalexin alone for pure cellulitis 1.
Renal Dosing Adjustments
Since you mention normal BUN and creatinine with a specific GFR value, standard dosing applies. However, for reference 2:
- GFR >30 mL/min: Standard dosing (1 DS tablet every 12 hours)
- GFR 15-30 mL/min: Reduce to half the usual dose
- GFR <15 mL/min: Use not recommended by FDA label
Recent pharmacokinetic data suggests more nuanced adjustments 4:
- GFR 30 mL/min/1.73m²: Reduce dose by 16.7%
- GFR 10 mL/min/1.73m²: Reduce dose by 33.3%
Weight-Based Considerations
While the FDA label provides standard tablet dosing 2, emerging evidence suggests weight-based dosing may improve outcomes. A multicenter study found that inadequate dosing (<5 mg TMP/kg/day) was independently associated with clinical failure in hospitalized cellulitis patients 5. For optimal outcomes, ensure the dose provides at least 5 mg/kg/day of the trimethoprim component 5.
For a patient weighing [WEIGHT]:
- Calculate: [WEIGHT in kg] × 5 mg = minimum daily trimethoprim dose needed
- Each DS tablet contains 160 mg trimethoprim
- Two DS tablets daily = 320 mg trimethoprim total
If the patient weighs >64 kg, standard dosing (2 DS tablets daily) may be suboptimal and higher doses should be considered 5.
Clinical Monitoring
Do not be misled by mild creatinine elevations: Trimethoprim competitively inhibits tubular creatinine secretion, causing a reversible 0.07 mg/dL median increase in serum creatinine that does not reflect true renal dysfunction 6. This is a benign pharmacologic effect, not nephrotoxicity. Only elevations ≥0.3 mg/dL warrant investigation for alternative causes 6.
Critical Safety Warning
Be vigilant for severe respiratory adverse effects. A recently described life-threatening adverse reaction—TMP-SMX-associated severe ARDS—occurs after ≥6 days of treatment dose (not prophylaxis) in previously healthy young patients 7. This carries a 40% mortality rate and is strongly associated with HLA-B07:02 and HLA-C07:02 alleles 7. If unexplained severe respiratory failure develops during treatment, immediately discontinue TMP-SMX and consider this diagnosis.
Adjunctive Measures
- Elevate the affected extremity to promote drainage
- Examine interdigital toe spaces for tinea pedis and treat if present (reduces recurrence risk)
- Address predisposing factors: edema, venous insufficiency, obesity, eczema